A study on neuroinflammation and NMDA receptor function in STZ (ICV) induced memory impaired rats

Journal of Neuroimmunology

Volumn 254, Issue 1-2, 2013, Pages 1-9

  Rai, Shivika ^a   Kamat, Pradeep K ^a   Nath, Chandishwar ^a   Shukla, Rakesh ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Memory impairment; Neuroinflammation; NMDA receptor; Streptozotocin

Indexed keywords

GUM ARABIC; IBUPROFEN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MEMANTINE; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; NEURONAL NITRIC OXIDE SYNTHASE; NITRITE; REACTIVE OXYGEN METABOLITE; RECEPTOR SUBUNIT; STREPTOZOCIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; GENE EXPRESSION; MALE; MEMORY DISORDER; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BRAIN; CYTOKINES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENCEPHALITIS; EXCITATORY AMINO ACID ANTAGONISTS; GENE EXPRESSION REGULATION; IBUPROFEN; INJECTIONS, INTRAVENTRICULAR; MALE; MAZE LEARNING; MEMANTINE; MEMORY DISORDERS; MOTOR ACTIVITY; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RECEPTORS, N-METHYL-D-ASPARTATE; RNA, MESSENGER; STATISTICS, NONPARAMETRIC; STREPTOZOCIN;

EID: 84871684881     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2012.08.008     Document Type: Article

References (41)

1. Agrawal R., Tyagi E., Shukla R., Nath C. A study of brain insulin receptors, AChE activity and oxidative stress in rat model of ICV STZ induced dementia. Neuropharmacology 2009, 56:779-787.
2. Banati R.B., Gehrmann J., Schubert P., Kreutzberg G.W. Cytotoxicity of microglia. Glia 1993, 7:111-118.
3. Bear M.F. Homosynaptic long-term depression: a mechanism for memory?. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:9457-9458.
4. Beattie E.C., Stellwagen D., Morishita W., Bresnahan J.C., Ha B.K., Von Zastrow M., Beattie M.S., Malenka R.C. Control of synaptic strength by glial TNF alpha. Science 2002, 295:2282-2285.
5. Bell K.F., Claudio Cuello A. Altered synaptic function in Alzheimer's disease. Eur. J. Pharmacol. 2006, 545:11-21.
6. Bradbury F. How important is the role of the physician in the correct use of a drug? An observational cohort study in general practice. Int. J. Clin. Pract. Suppl. 2004, 144:27-32.
7. Chang Y.C., Kim H.W., Rapoport S.I., Rao J.S. Chronic NMDA administration increases neuroinflammatory markers in rat frontal cortex: cross-talk between excitotoxicity and neuroinflammation. Neurochem. Res. 2008, 33:2318-2323.
8. Dawson V.L., Dawson T.M., Bartley D.A., Uhl G.R., Snyder S.H. Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J. Neurosci. 1993, 13:2651-2661.
9. Deak T., Bellamy C., D'Agostino L.G. Exposure to forced swim stress does not alter central production of IL-1. Brain Res. 2003, 972:53-63.
10. During M.J., Symes C.W., Lawlor P.A., Lin J., Dunning J., Fitzsimons H.L., Poulsen D., Leone P., Xu R., Dicker B.L., Lipski J., Young D. An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy. Science 2000, 287:1453-1460.
11. Floyd R.A. Neuroinflammatory processes are important in neurodegenerative diseases: an hypothesis to explain the increased formation of reactive oxygen and nitrogen species as major factors involved in neurodegenerative disease development. Free Radic. Biol. Med. 1999, 26:1346-1355.
12. Glowinski J., Iversen L.L. Regional studies of catecholamines in the rat brain. I. The disposition of [3H] norepinephrine, [3H] dopamine and [3H] dopa in various regions of the brain. J. Neurochem. 1966, 13:655-669.
13. Green L.C., Wagner D.A., Glogowski J., Skipper P.L., Wishnok J.S., Tannenbaum S.R. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal. Biochem. 1982, 126:131-138.
14. Heneka M.T., Wiesinger H., Dumitrescu-Ozimek L., Riederer P., Feinstein D.L., Klockgether T. Neuronal and glial coexpression of argininosuccinate synthetase and inducible nitric oxide synthase in Alzheimer disease. J. Neuropathol. Exp. Neurol. 2001, 60:906-916.
15. Jaturapatporn D., Isaac M.G., McCleery J., Tabet N. Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease. Cochrane Database Syst. Rev. 2012, 2:63-78.
16. Kamat P.K., Tota S., Saxena G., Shukla R., Nath C. Okadaic acid (ICV) induced memory impairment in rats: a suitable experimental model to test anti-dementia activity. Brain Res. 2010, 1309:66-74.
17. Lewis D.A. Development of the prefrontal cortex during adolescence: insights into vulnerable neural circuits in schizophrenia. Neuropsychopharmacology 1997, 16:385-398.
18. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
19. Malenka R.C., Nicoll R.A. Long-term potentiationa decade of progress?. Science 1999, 285:1870-1874.
20. Massey P.V., Johnson B.E., Moult P.R., Auberson Y.P., Brown M.W., Molnar E., Collingridge G.L., Bashir Z.I. Differential roles of NR2A and NR2B-containing NMDA receptors in cortical long-term potentiation and long-term depression. J. Neurosci. 2004, 24:7821-7828.
21. Min S.S., Quan H.Y., Ma J., Han J.S., Jeon B.H., Seol G.H. Chronic brain inflammation impairs two forms of long-term potentiation in the rat hippocampal CA1 area. Neurosci. Lett. 2009, 456:20-24.
22. Minghetti L., Levi G. Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide. Prog. Neurobiol. 1998, 54:99-125.
23. Monyer H., Burnashev N., Laurie D.J., Sakmann B., Seeburg P.H. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 1994, 12:529-540.
24. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods 1984, 11:47-60.
25. Mrak R.E., Griffin W.S. Glia and their cytokines in progression of neurodegeneration. Neurobiol. Aging 2005, 26:349-354.
26. Murphy S. Production of nitric oxide by glial cells: regulation and potential roles in the CNS. Glia 2000, 29:1-13.
27. Paxinos G., Watson C.R., Emson P.C. AChE-stained horizontal sections of the rat brain in stereotaxic coordinates. J. Neurosci. Methods 1980, 3:129-149.
28. Perez-Otano I., Ehlers M.D. Learning from NMDA receptor trafficking: clues to the development and maturation of glutamatergic synapses. Neurosignals 2004, 13:175-189.
29. Prast H., Philippu A. Nitric oxide as modulator of neuronal function. Prog. Neurobiol. 2001, 64:51-68.
30. Sachdeva R., Babbar R., Puri V., Agarwal S., Krishana B. Correlation between cognitive functions and nitric oxide levels in patients with dementia. Clin. EEG Neurosci. 2011, 42:190-194.
31. Schipke C.G., Ohlemeyer C., Matyash M., Nolte C., Kettenmann H., Kirchhoff F. Astrocytes of the mouse neocortex express functional N-methyl-d-aspartate receptors. FASEB J. 2001, 15:1270-1272.
32. Shoham S., Bejar C., Kovalev E., Weinstock M. Intracerebroventricular injection of streptozotocin causes neurotoxicity to myelin that contributes to spatial memory deficits in rats. Exp. Neurol. 2003, 184:1043-1052.
33. Socci D.J., Bjugstad K.B., Jones H.C., Pattisapu J.V., Arendash G.W. Evidence that oxidative stress is associated with the pathophysiology of inherited hydrocephalus in the H-Tx rat model. Exp. Neurol. 1999, 155:109-117.
34. Soliven B., Albert J. Tumor necrosis factor modulates Ca2+ currents in cultured sympathetic neurons. J. Neurosci. 1992, 12:2665-2671.
35. Tan Z.S., Beiser A.S., Vasan R.S., Roubenof R., Dinarello C.A., Harris T.B., Benjamin E.J., Au R., Kiel D.P., Wolf P.A., Seshadri S. Inflammatory markers and the risk of Alzheimer disease: the Framingham Study. Neurology 2007, 68:1902-1928.
36. Tarkowski E., Liljeroth A.M., Minthon L., Tarkowski A., Wallin A., Blennow K. Cerebral pattern of pro- and anti-inflammatory cytokines in dementias. Brain Res. Bull. 2003, 61:255-260.
37. Toms N.J., Roberts P.J. NMDA receptor-mediated stimulation of rat cerebellar nitric oxide formation is modulated by cyclic AMP. Eur. J. Pharmacol. 1994, 266:63-66.
38. Tweedie D., Sambamurti K., Greig N.H. TNF-alpha inhibition as a treatment strategy for neurodegenerative disorders: new drug candidates and targets. Curr. Alzheimer Res. 2007, 4:378-385.
39. Tyagi E., Agrawal R., Nath C., Shukla R. Influence of LPS-induced neuroinflammation on acetylcholinesterase activity in rat brain. J. Neuroimmunol. 2008, 205:51-56.
40. Wong R. NMDA receptors expressed in oligodendrocytes. Bioessays 2006, 28:460-464.
41. Yoshiyama M., Groat W.C. Role of spinal metabotropic glutamate receptors in regulation of lower urinary tract function in the decerebrate unanesthetized rat. Neurosci. Lett. 2007, 420:18-22.